Carr’s Group enters partnership with Vétalis

Carr's Group plc (LSE: CARR), a global leader in sustainable livestock supplements, announces it has entered into a strategic manufacturing partnership with French company Vétalis to develop an advanced range of Tracesure® boluses, with distribution scheduled from Autumn 2025.

The new partnership follows the strategic decision to close the ANIMAX production facility in June 2025 and enables the Group to allocate more resources toward innovation and meeting the demands of a growing market. Vétalis is a recognised expert in precision bolus supplementation technology and brings strong capabilities in developing science-backed solutions that support livestock health and sustainable farming practices.

The partnership marks a pivotal step in the Group's growth strategy by improving on-farm productivity which in turn supports sustainable global food security. By combining the Group's deep understanding of livestock nutrition with Vétalis' advanced manufacturing, the partnership will propel innovation, drive operational efficiencies, and improve product delivery. The agreement is expected to deliver meaningful operational savings while reinforcing the market-leading position of Tracesure® in the UK and Ireland.

Joshua Hoopes, Chief Executive Officer of Carr's Group plc commented: "This is a key strategic milestone as we reposition the Group as a focused, pure-play agriculture business. Partnering with Vétalis enables us to build a more efficient platform for sustainable growth, while strengthening our customer offering and creating long-term value for shareholders."

Headquartered in Carlisle, Cumbria, Carr's Group operates 7 manufacturing sites across the UK, Germany and the USA, and serves customers in more than 20 countries through its expansive global distribution and support network.

Carr's Group plc has been listed on the London Stock Exchange since 1972 under the ticker "CARR".